TrialAlzheimer's research & therapy2025

First-in-human study of neuron regenerative therapy NNI-362 to evaluate the safety, pharmacokinetics, and pharmacodynamics in healthy aged population.

Judith Kelleher-Andersson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.